Editorial: Placebo harm

Drug Safety

Volumn 33, Issue 6, 2010, Pages 439-441

  Edwards, I Ralph ^a   Graedon, Joe ^b   Graedon, Terry ^b  

^a UPPSALA MONITORING CENTRE   (Sweden)

^b Peoples Pharmacy   (United States)

Author keywords

Adverse reaction monitoring; Clinical trial design; Pharmacovigilance; Placebo response

Indexed keywords

PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ALLOPATHY; ANALGESIA; ASTHMA; BLOOD PRESSURE; CLINICAL TRIAL; DRUG RESPONSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; FEVER; HEALTH CARE PERSONNEL; HEART RATE; HUMAN; IMMUNE RESPONSE; MUSCLE STRENGTH; MUSCLE TONE; PARKINSON DISEASE; PATIENT SAFETY; PLACEBO EFFECT; PLACENTA DISORDER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSORIMOTOR FUNCTION; SHAM PROCEDURE; WITCHCRAFT; CONTROLLED CLINICAL TRIAL; METHODOLOGY; NOTE; RESEARCH SUBJECT;

CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; PLACEBOS; RESEARCH SUBJECTS;

EID: 77952791315     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11532400-000000000-00000     Document Type: Editorial

References (4)

1. Rief W, Nestoriuc Y, von Lilienfeld-Toal A, et al. Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf 2009; 32 (11): 1041-1056
2. Silberman S. Placebos are getting more effective: drugmakers are desperate to know why [online]. Available from URL: http://www.wired.com/ medtech/drugs/magazine/17-09/ff-placebo-effect?currentPage=all [Accessed 2010 Mar 29]
3. Kennedy WP. The nocebo reaction. Med Exp Int J Exp Med 1961; 95: 203-205
4. Levine ME, Stern RM, Koch KL. The effects of manipulating expectations through placebo and nocebo administration on gastric tachyarrhythmia and motion-induced nausea. Psychosom Med 2006; 68: 478-486